A previous study suggested that HCV-Ab positive patients are more likely to have an incomplete CD4+ restoration [33], whereas others suggested that previous intravenous drug use, but not HCV co-infection, is associated with suboptimal CD4 response to HAART. The gene discussed is CD4; the disease is coinfection.